BIOSENSE WEBSTER INC CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ SMALL; INTRODUCER, CATHETER
|
Back to Search Results |
|
Model Number D138501 |
Device Problem
Material Separation (1562)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 08/30/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
(b)(6).This report is being submitted pursuant to the provisions of 21 cfr, part 4.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.(b)(4).
|
|
Event Description
|
It was reported that a patient underwent a cardiac ablation procedure with a carto vizigo¿ 8.5f bi-directional guiding sheath ¿ small and a hemostatic valve separation issue occurred.It was reported that there was a hemostatic valve defect.The hemostatic valve fell into the hub.The issue was confirmed at insertion into sheath.The issue was resolved by changing the vizigo¿ to another one.The procedure was then successfully completed without patient consequence.
|
|
Manufacturer Narrative
|
The device evaluation was completed on 23-nov-2022.It was reported that a patient underwent a cardiac ablation procedure with a carto vizigo¿ 8.5f bi-directional guiding sheath ¿ small and a hemostatic valve separation issue occurred.It was reported that there was a hemostatic valve defect.The hemostatic valve fell into the hub.The issue was confirmed at insertion into sheath.The issue was resolved by changing the vizigo¿ to another one.The procedure was then successfully completed without patient consequence.Device evaluation details: the product was returned to biosense webster inc.(bwi) for evaluation.Visual inspection and microscopic examination of the returned device were performed following bwi procedures.Visual analysis revealed that the hemostatic valve was broken inside the hub component.Microscopic examination of the hemostatic valve surface showed stress marks on the outer diameter.The stress marks suggest that excessive force or manipulation was applied due to an extreme off axis angle of insertion.Valve damage occurs when extreme off axis angles is performed during insertion with the dilator, outside of what is recommended in the odp (optimal device performance guide).A device history record (dhr) review was performed for the finished device 00001994 number, and no internal action related to the complaint were found during the review.Based on the dhr, the h 4.Device manufacture date has been updated.The issue reported by the customer was confirmed.The odp contains the following caution: always insert a dilator straight into the center of the sheath¿s valve to prevent damage to the valve.Do not insert a dilator at an angle, as damage to the sheath valve may occur.As part of the quality process, all devices are manufactured, inspected, and released to approved specifications.This product issue will be addressed through bwi's quality system.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Manufacturer Narrative
|
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: pc-001190776 additional information was received on (b)(6)2022.This information was inadvertently omitted on follow up report #1( mwr-20102022-0001282982) it was reported that the sheath was being used on the patient.Air did not enter the patient¿s body, therefore were no patient consequences and no treatment was required.No blood return was observed.
|
|
Manufacturer Narrative
|
The biosense webster, inc.Product analysis lab received the device for evaluation.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Search Alerts/Recalls
|
|
|